# Lipocine Inc.: Form 8-K, filed Dec 15, 2025

- Company: [Lipocine Inc.](/companies/lpcn.md) (CIK 1535955)
- Form: 8-K
- Filed: 2025-12-15
- Accepted by EDGAR: Dec 15, 2025, 16:05 ET
- Period: 2025-12-12
- Accession: 0001493152-25-027744
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1535955/000149315225027744/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1535955/000149315225027744/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1535955/000149315225027744/form8-k.htm

Filed Dec 15, 2025.
Source: SEC EDGAR, the filing index for accession 0001493152-25-027744. Last ingested by Listed: Nov 5, 2026, 12:44 ET. No prices; not investment advice.